Update August 2023:Dr. Forsythehas has now developed “The Forsythe Immune Protocol” (FIP). His treatment plan, in a current study of over ten years in 2,000 adult cancer patients, has produced a remarkable 68% overall survival rate.
Update August 2012:This article was written in 2002. Poly MVA has since taken hold and you can read about Dr. James Forsythe, MD, HMD, board certified oncologist, who started the Cancer Wards at each of the 3 major Nevada hospitals and ran the Cancer Program at the VA Medical Center, discuss this remarkable substance.
Following is a description of a patented compound called Polydox or Poly-MVA which appears to meet the criteria of being non-toxic to normal cells yet lethal to malignant ones.
Tumor Cell Specific Killing
In 1931, Otto Warburg was awarded a Nobel Prize for being the first to identify respiratory enzymes and discovering that cancer cell respiration was glycolytic instead of oxygen dependent. He found that cancer development caused a major change in energy metabolism.
Based on Warbrug's findings, in 1995, Merrill Garnett was issued a patent for a novel cancer chemotherapeutic agent which attacks a target which is only found in malignant cells and is related to specific changes in energy metabolism. This compound has been named Polydox (U.S. trials) or Poly-MVA (Canada & Mexico) or LAPd by some researchers. The MVA stands for minerals, vitamins and aminoacids. LAPd stands for Lipoic Acid / Palladium complex.
Cancer is now considered a systematic, as opposed to a local, disease and its cause is multifactorial. Poly MVA attacks one of the root causes of cancer. It is a complex of lipoic acid, palladium, B12 and other B complex vitamins connected to a metal substrate. The complex is very soluble in water and fat. Therefore it travels all over the body and into every cell. It is classified as a nucleotide reductase.
Paul M. Bingham of State University of New York's Department of Biochemistry and Cell Biology clearly demonstrated from a molecular and cell biological perspective the anti-tumor activity of Poly MVA. Other therapeutic benefits from these compounds are related to the effect on the body systems of the antioxidant power of the Lipoic acid and the known benefits of B-12 and the other B vitamins. These have been reported as increased energy, improved appetite and pain control measured by reduction of the need for pain medication.